GSK has agreed to acquire RAPT Therapeutics, adding food allergy drug candidates to its pipeline. The company has received expanded European Commission approval for its RSV vaccine Arexvy for adults ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results